Gregory David Casciaro

Gregory David Casciaro currently works at Colospan Ltd., as Independent Director from 2021, Yor Labs, Inc., as Director from 2022, Tulavi Therapeutics, Inc., as Director, KL Acquisition Corp., as Independent Director from 2021, and Cytokind, Inc., as Director.
Mr. Casciaro also formerly worked at General Surgical Innovations, Inc., as President & Chief Executive Officer from 1995 to 1999, Cardiac Dimensions, Inc., as President, Chief Executive Officer & Director from 2015 to 2020, Access Closure, Inc., as President, Chief Executive Officer & Director from 2010 to 2014, Xtent, Inc., as President & Chief Executive Officer from 2004 to 2009, Orquest, Inc., as President, Chief Executive Officer & Director from 2000 to 2003, Foldax, Inc., as Chief Executive Officer, Kerberos Proximal Solutions, Inc., as Director from 2005 to 2006, Trireme Medical LLC, as Director from 2010 to 2013, Apama Medical, Inc., as Director from 2014 to 2017, AngioDynamics, Inc., as Director from 2004 to 2008, Dex Liquidating Co., as Director from 2014 to 2018, QT Vascular Ltd., as Independent Non-Executive Director from 2001 to 2021, North American Instrument Corp., as Manager-Area Sales, and Devices for Vascular Intervention, Inc., as Vice President-Sales in 1995.
Mr. Casciaro received his undergraduate degree in 1982 from Marquette University.